ARUK 2019 | Epigenomic changes in Alzheimer’s: ANK1 DNA methylation

Katie Lunnon

Katie Lunnon, PhD, PGCAP, of the University of Exeter, Exeter, UK, discusses the last 5 years in epigenomics for Alzheimer’s. She highlights studies of ANK1 DNA methylation across different neurodegenerative diseases, and explains her further plans for study in this area. This interview took place at the Alzheimer’s Research UK (ARUK) Conference 2019, held in Harrogate, UK.

Share this video